Cargando…

P614: NOVEL SPLICE-SITE MUTATION IN PLCG2 ASSOCIATED WITH RESISTANCE TO BTK INHIBITORS

Detalles Bibliográficos
Autores principales:	Qi, Jialei, Wist, Martin, Tausch, Eugen, Yordanov Yosifov, Deyan, Schade, Anja, Gao, Xiang, Priyadharshini Dheenadayalan, Rashmi, Schneider, Christof, Endres, Sascha, Mertens, Daniel, Gierschik, Peter, Stilgenbauer, Stephan, Michael Chelliah Jebaraj, Billy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429041/ http://dx.doi.org/10.1097/01.HS9.0000969360.69911.52

Ejemplares similares

Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors
por: Qi, Jialei, et al.
Publicado: (2023)

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
por: Zapatka, Marc, et al.
Publicado: (2021)

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
por: Yosifov, Deyan Yordanov, et al.
Publicado: (2020)

Telomere Dysfunction in Chronic Lymphocytic Leukemia
por: Jebaraj, Billy Michael Chelliah, et al.
Publicado: (2021)

PB1912: BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR
por: Likold, Ekaterina, et al.
Publicado: (2023)

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
por: Bonfiglio, Silvia, et al.
Publicado: (2023)

From Biology to Therapy: The CLL Success Story
por: Yosifov, Deyan Y., et al.
Publicado: (2019)

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBINED TIME-LIMITED TREATMENT WITH ANTI-CD20 ANTIBODY + IBRUTINIB, IDELALISIB OR VENETOCLAX IN THE GCLLSG CLL2-BAG, -BCG, -BIG AND -BIO PHASE-II TRIALS
por: Yosifov, Deyan, et al.
Publicado: (2023)

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
por: Bloehdorn, Johannes, et al.
Publicado: (2021)

Advances in treating chronic lymphocytic leukemia
por: Tausch, Eugen, et al.
Publicado: (2014)

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
por: Tausch, Eugen, et al.
Publicado: (2020)

Functional characterization of phospholipase C-γ(2) mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder
por: Walliser, Claudia, et al.
Publicado: (2018)

Recurrent PTPRB and PLCG1 mutations in angiosarcoma
por: Behjati, Sam, et al.
Publicado: (2014)

Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa
por: Neves, João Farela, et al.
Publicado: (2018)

Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes
por: Shiseki, Masayuki, et al.
Publicado: (2019)

Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant
por: Ferri-Lagneau, Karine F., et al.
Publicado: (2019)

PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease
por: Tsai, Andy P., et al.
Publicado: (2022)

Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK
por: Kueffer, Lauren E., et al.
Publicado: (2021)

Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose
por: Walker, Kiera, et al.
Publicado: (2018)

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
por: Martín-Nalda, Andrea, et al.
Publicado: (2020)

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma
por: Li, Zhengtian, et al.
Publicado: (2021)

Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2
por: Peng, Qi, et al.
Publicado: (2023)

Laser Spectroscopy of Tin across N = 82
por: Yordanov, Deyan
Publicado: (2016)

From $^{27}$Mg to ${33}$Mg: transition to the "Island of inversion"
por: Yordanov, Deyan
Publicado: (2012)

Differential impact of BTK active site inhibitors on the conformational state of full-length BTK
por: Joseph, Raji E, et al.
Publicado: (2020)

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2023)

Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
por: Magno, Lorenza, et al.
Publicado: (2019)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage
por: Huang, Sheng-Yu, et al.
Publicado: (2021)

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
por: Bloehdorn, Johannes, et al.
Publicado: (2021)

Cytotoxicity of gypsogenic acid isolated from Gypsophila trichotoma
por: Krasteva, Ilina, et al.
Publicado: (2014)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene
por: Khan, Safayat Mahmud, et al.
Publicado: (2021)

Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review
por: Welzel, Tatjana, et al.
Publicado: (2022)

BTK: sensing pathogenic nucleic acids
por: Lee, Koon-Guan, et al.
Publicado: (2015)

A Fast and Clean BTK Inhibitor
por: Gabizon, Ronen, et al.
Publicado: (2020)

The race to stymie BTK: zanu zings
por: Kapoor, Prashant, et al.
Publicado: (2020)

Targeting Solid Tumors With BTK Inhibitors
por: Uckun, Fatih M., et al.
Publicado: (2021)

BTK, the new kid on the (oncology) block?
por: Grassilli, Emanuela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n91rthfv2n0tqvfnn4be9d2u6h